Navigation Links
Medivation Reports Third Quarter 2008 Financial Results and Provides Corporate Update
Date:11/10/2008

ion upon the attainment of development and

regulatory milestones, plus additional undisclosed commercial milestone

payments.

-- Enrollment in CONNECTION, our confirmatory Phase 3 trial in

mild-to-moderate Alzheimer's disease, continues on track. All 30 of

our U.S. sites have been opened, and we expect the majority of our

ex-U.S. sites to be opened by the end of November. We expect to

complete enrollment of this trial in 2009.

-- Completed a randomized, double-blind safety and tolerability study of

combination therapy with Dimebon and donepezil (Aricept(R)) in patients

with Alzheimer's disease, which found the combination to be well

tolerated with no serious adverse events.

-- Plan to initiate new Phase 3 studies in 2009 to seek further

differentiation of Dimebon to include moderate-to-severe Alzheimer's

disease, adjunctive use with cholinesterase inhibitors, and

twelve-month efficacy.

-- Received a Corporate Achievement Award from the Huntington's Disease

Society of America (HDSA) for exemplifying leadership in the fight

against Huntington's disease and other neurodegenerative diseases.

-- Plan to initiate the next Huntington's disease efficacy study in 2009.

MDV3100: Drug candidate to treat castration-resistant prostate cancer

-- Presented data at the 20th EORTC-NCI-AACR Symposium on "Molecular

Targets and Cancer Therapeutics" from an ongoing open-label,

dose-escalation, U.S.-based Phase 1-2 clinical trial in prostate cancer

patients who have failed standard hormonal therapies. Results showed

encouraging and durable anti-tumor activity in the three expanded dose

groups tested thus far, as measured by prostate specific antigen (PSA)

declines, radiographic findings, circulating tumor cell (CTC) changes,

and time on treatment. MDV
'/>"/>

SOURCE Medivation, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Medivation Announces Third Quarter 2008 Teleconference and Webcast on November 10, 2008
2. Medivation Announces Expiration of Hart-Scott-Rodino Waiting Period for Collaboration With Pfizer
3. Medivation Announces Presentation of 24-Week Clinical Data of MDV3100 in Castration-Resistant Prostate Cancer Patients
4. Medivation Receives Corporate Achievement Award From Huntingtons Disease Society of America
5. Medivation to Host Conference Call at 8:30 a.m. Eastern Time Tomorrow to Discuss Partnering Plans for Dimebon
6. Medivation Announces Participation in Upcoming Conferences
7. Medivation Reports Second Quarter 2008 Financial Results and Provides Corporate Update
8. Medivation Announces Second Quarter 2008 Teleconference and Webcast on August 11, 2008
9. Medivation Announces Presentation at the BMO Capital Markets 2008 Focus on Healthcare Conference on August 5
10. Medivation Announces Presentation of Positive MDV3100 Clinical Data in Castration-Resistant Prostate Cancer Patients
11. Medivation Announces Senior Management Promotions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... particle be separated from its properties? On July 29, ... results of the first Cheshire Cat experiment, separating a ... in Orange, CA, and Vienna University of Technology. , ... grin," thought Alice in Wonderland, "but a grin without ... saw in my life!" Alice,s surprise stems from her ...
(Date:7/29/2014)... has created a new way of manufacturing microstructured ... made by self-assembly of carbon nanotubes, could exhibit ... mechanical stiffness and strength, or the ability to ... have demonstrated that mechanical forces can be used ... and that we can independently control the ...
(Date:7/29/2014)... , July 29, 2014  Pomerantz LLP is investigating ... ("Impax" or the "Company") (NASDAQ: IPXL).  Such investors are ... rswilloughby@pomlaw.com or 888-476-6529, ext. 237. ... officers and/or directors have violated Sections 10(b) and 20(a) ... On July 29, 2014, Impax Laboratories, Inc. (the ...
(Date:7/29/2014)... 29, 2014 According to the ... Imaging), Analytics (Image Analysis Software), Delivery Modes (Web Based/Cloud ... & Trends to 2018", published by MarketsandMarkets, analyzes and ... such as North America , ... and the Rest of the World (RoW). ...
Breaking Biology Technology:The quantum Cheshire cat: Scientists separate a particle from its properties 2The quantum Cheshire cat: Scientists separate a particle from its properties 3The quantum Cheshire cat: Scientists separate a particle from its properties 4A new way to make microstructured surfaces 2SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Impax Laboratories, Inc. - IPXL 2Digital Pathology Market worth $437 Million by 2018 2Digital Pathology Market worth $437 Million by 2018 3
... Oct. 26 AMN Healthcare Services,Inc. (NYSE: ... is,scheduled to make a presentation on Thursday, November ... BIOCOM Investor Conference 2007 taking place at the ... (Logo: http://www.newscom.com/cgi-bin/prnh/20060718/LATU121LOGO ) Susan R. ...
... Salugen, Inc., a personalized health,and wellness company ... release activator] results in significant,reductions in weight, ... population in,the Dietary Investigation to Evaluate Treatments ... Deficiency Syndrome (RDS) at the,Second Bruce Ames ...
... PURE Bioscience (OTC,Bulletin Board: PURE), creators of ... a revolutionary new hard surface,disinfectant which kills Staph/MRSA ... Company will present at the Biocom Investor Conference,on ... Marriott Del Mar. Michael L.,Krall, CEO, will discuss ...
Cached Biology Technology:AMN Healthcare Services to Present at the BIOCOM Investor Conference 2007 2Salugen's Award-Winning Research on Using DNA Information to Customize Nutritional Supplementation for Weight Loss Presented at the Second Annual Bruce Ames International Symposium on Nutritional Genomics at the University of California, Davis 2PURE Bioscience to Present at Biocom Investors Conference 2PURE Bioscience to Present at Biocom Investors Conference 3PURE Bioscience to Present at Biocom Investors Conference 4
(Date:7/29/2014)... A new study from UC San Francisco is the ... stressors accumulate overtime and accelerate cellular aging, these negative ... exercising and sleeping well. , "The study participants ... telomere shortening than the ones who didn,t maintain healthy ... said lead author Eli Puterman, PhD, assistant professor in ...
(Date:7/28/2014)... the United States have a circulatory problem of the ... and may even require surgery in serious cases. This ... in turn, limb amputation. , At The University of ... scientists tested a non-surgical preventative treatment in a mouse ... increased blood circulation. Their proof-of-concept study appears in ...
(Date:7/28/2014)... a wild relative of the domestic tomato, has been ... labs headed by Professors Neelima Sinha and Julin Maloof ... new genome information may help breeders produce tastier, more ... the journal Nature Genetics , was lead by ... The UC Davis labs carried out work on the ...
Breaking Biology News(10 mins):Healthy lifestyle may buffer against stress-related cell aging, study says 2Scientists discover genetic switch that can prevent peripheral vascular disease in mice 2
... it comes to producing more offspring, larger female hyenas outdo ... University researchers, which appears in Proceedings of the Royal ... way to measure spotted hyenas, size. "This is the ... lifetime selection on a large carnivore," said MSU graduate student ...
... , NEW YORK (March 23, 2011)The job of promoting conservation ... the birds, according to the authors of a new bird ... and Editora Horizonte in Sao Paulo, Brazil., Published in Portuguese ... Central Brazil" highlights the bird life of one of the ...
... A new research report published online in The FASEB ... high sugar and high fat diets have babies who are ... report, which used rats, this happens because the high fat ... brain,s reward pathway, altering food preferences. Not only does this ...
Cached Biology News:Larger female hyenas produce more offspring 2WCS releases 'Birds of Brazil' 2WCS releases 'Birds of Brazil' 3'Junk food' moms have 'junk food' babies 2
Mouse IL-31 RA Biotinylated Affinity Purified PAb...
... 8 micro-bore tubes to 1 outflow Single-cell ... Rapid (several millisecond) solution change Very ... , Solid construction 360, 250 and ... For mounting on any micromanipulator Available in ...
... High Five cells (BTI-TN-5B1-4) derived from ... been shown to be capable of ... recombinant proteins compared to other insect ... following features:- -Rapid doubling time as adherent ...
... Promega Flipper® Racks are ideal for storage ... tubes. These polypropylene racks withstand extreme temperatures, ... storage. They may also be autoclaved for ... two-sided; one side accommodates 0.5ml microcentrifuge tubes, ...
Biology Products: